Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 6, 2013
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapyPablo Barreiro, Pablo Labarga, José V Fernández-Montero, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2008
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcomePilar García-Gascó, Ivana Maida, Francisco Blanco, et al.
Antiviral Therapy|November 7, 2013
Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapyJosé V Fernández-Montero, Pablo Barreiro, Eugenia Vispo, et al.
Current HIV/AIDS Reports|July 10, 2015
Emerging challenges in managing hepatitis B in HIV patientsVincent Soriano, Pablo Labarga, Carmen de Mendoza, et al.
AIDS Research and Human Retroviruses|August 17, 2006
Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosineJosé Miguel Benito, Mariola López, Celia Ballesteros, et al.
Infectious Disorders Drug Targets|June 22, 2006
Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond lessVincent Soriano, Marina Nuñez, Javier Garcia-Samaniego, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patientsEugenia Vispo, Muge Cevik, Juergen K Rockstroh, et al.
The Journal of Infectious Diseases|March 3, 2007
Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis CPablo Barreiro, Sonia Rodríguez-Novoa, Pablo Labarga, et al.
AIDS (London, England)|February 16, 2010
Survival of HIV-infected patients with compensated liver cirrhosisPaula Tuma, Inmaculada Jarrin, Julia Del Amo, et al.
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurementsInmaculada Jiménez-Nácher, Benito García, Pablo Barreiro, et al.
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 6, 2013
Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapyPablo Barreiro, Pablo Labarga, José V Fernández-Montero, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2008
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcomePilar García-Gascó, Ivana Maida, Francisco Blanco, et al.
Antiviral Therapy|November 7, 2013
Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapyJosé V Fernández-Montero, Pablo Barreiro, Eugenia Vispo, et al.
Current HIV/AIDS Reports|July 10, 2015
Emerging challenges in managing hepatitis B in HIV patientsVincent Soriano, Pablo Labarga, Carmen de Mendoza, et al.
AIDS Research and Human Retroviruses|August 17, 2006
Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosineJosé Miguel Benito, Mariola López, Celia Ballesteros, et al.
Infectious Disorders Drug Targets|June 22, 2006
Chronic hepatitis C in HIV-infected patients: those who more need therapy are those who respond lessVincent Soriano, Marina Nuñez, Javier Garcia-Samaniego, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patientsEugenia Vispo, Muge Cevik, Juergen K Rockstroh, et al.
The Journal of Infectious Diseases|March 3, 2007
Influence of liver fibrosis stage on plasma levels of antiretroviral drugs in HIV-infected patients with chronic hepatitis CPablo Barreiro, Sonia Rodríguez-Novoa, Pablo Labarga, et al.
AIDS (London, England)|February 16, 2010
Survival of HIV-infected patients with compensated liver cirrhosisPaula Tuma, Inmaculada Jarrin, Julia Del Amo, et al.
The Journal of Antimicrobial Chemotherapy|June 24, 2008
Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurementsInmaculada Jiménez-Nácher, Benito García, Pablo Barreiro, et al.
Pageof 22